The Terry Fox Research Institute (TFRI) is seeking applications for two of its prestigious grant programs: The Terry Fox New Frontiers Program and the Terry Fox New Investigators Awards.
Both peer-reviewed grant programs focus on supporting excellence and collaboration in cancer research. They're main goal is to move discoveries from the laboratory to the clinic more quickly for the benefit of cancer patients.
Terry Fox New Frontiers Program
The Terry Fox New Frontiers Program Project Grants is a long?standing program involving the best cancer researchers in Canada. These programs support Canadian research teams exploring new frontiers in cancer research (i.e., breakthrough and transformative biomedical, clinical and translational research which may form the basis for innovative cancer prevention, diagnosis and/or treatment).
New Applicants for the Terry Fox New Frontiers Program Project Grants may be supported for a maximum of four years, with a budget of up to $400,000 in the first year followed by up to $600,000 per year for the next three years. Meanwhile, renewing applicants may receive up to $1,000,000 per annum for a maximum of six years
Current recipients include:
| Program |
Dates funded |
Program lead(s) |
| Exploiting Pathogenic Mechanisms in Acute Leukemia for Clinical Translation |
2017-2022 |
Karsan, Aly |
| Canadian Oncolytic Virus Consortium (COVCo) |
2017-2022 |
Bell, John |
| Nanoparticle-Enhanced Photoacoustic Imaging for Cancer Localization and Therapeutic Guidance |
2017-2022 |
Zheng, Gang |
| Delineating Therapeutic Opportunities in Triple-Negative Breast Cancer |
2016-2019 |
Lupien, Mathieu |
| Targeting clonal heterogeneity in treatment-refractory glioblastoma with novel and empiric immunotherapies |
2016-2019 |
Singh, Sheila |
Targeting the Hippo Signaling Network in Cancer
|
2016-2019 |
Wrana, Jeff |
Targeting the adaptive molecular landscape in castrate-resistant prostate cancer
|
2016-2021 |
Gleave, Martin |
| Overcoming Treatment Failure in Lymphoid Cancers |
2016-2021 |
Connors, Joseph |
| Development of Stemness-Based Prognostic Biomarkers and Therapeutic Targets |
2015-2020 |
Dick, John |
| Oncometabolism and the Molecular Pathways that Fuel Cancer |
2015-2019 |
Giguere, Vincent |
| Killing the Hydra: genetic dissection of actionable targets required for maintenance of metastatic disease |
2011-2019 |
Egan, Sean |
| A research pipeline for hypoxia-directed precision cancer medicine |
1999-2019 |
Bristow, Robert; Wouters, Bradly |
| Li-Fraumeni Syndrome: Applying Genetic Determinants of Cancer Risk to Cancer Surveillance and Prevention |
2015-2018 |
Malkin, David |
| Discovery and Therapeutic Development of Antibody-Based Targets in Oncology |
2015-2018 |
Jones, Steven |
| Genomics of forme fruste tumours: new vistas on cancer biology and management |
2010-2018 |
Huntsman, David |
For more information on the Terry Fox New Frontiers Program 2019 grants, including application guidelines and deadlines, please visit the award site:
Terry Fox New Investigator Awards
The Terry Fox New Investigators Awards provides research operating grant support to future leaders as they develop their independent careers in cancer research. Designed to provide a single research grant to scientific and clinical investigators within the first five years of a first faculty-level appointment in Canada, new investigators have to be sponsored and mentored by an existing Terry Fox funded program.
The 2019 Terry Fox New Investigators Awards add up to $150,000 per annum, and are tenable for three years.
Current recipients include:
| Name |
Start/End |
Project |
Trevor Pugh
|
2017-2020 |
Single cell dissection and non-invasive monitoring of childhood cancer |
Housheng Hansen He
|
2017-2020 |
Understanding the function of circular RNA in tumour hypoxia
|
Frederick Antoine Mallette
|
2017-2020
|
Deciphering the oncogenic properties of cancer-associated IDH1/2 mutations
|
Peter Stirling
|
2017-2020
|
Functionalizing SWI/SWF chromatin remodeller mutations in rare and common tumours
|
Guy Ungerechts
|
2016-2019 |
Next Generation Cancer Immunovirotherapy: Heterologous oncolytic prime-boost enhanced with select immunomodulators |
Ralph DaCosta
|
2016-2019 |
Investigating radiation responses of pancreatic tumours, their vasculature and microenvironment using in vivo imaging to identify new treatment strategies |
William Lockwood
|
2016-2019 |
Assessing the effect of radiation from screening low dose CT scans on lung cancer development and progression |
Byram Bridle
|
2015-2019
NCE |
Evaluation of oncolytic immunotherapy in canine cancer trials: A stepping stone towards successful translation into human patients |
Martin Hirst
|
2015-2018
NCE
|
Epigenetic basis of acute myeloid leukemia
|
Ryan Morin
|
2015-2018
NCE
|
Exploring Clonal Evolution in Non-Hodgkin Lymphomas Using Serial Tumour Sampling and Liquid Biopsies
|
Sachin Katyal
|
2018-2021 |
Targeting resistant glioblastoma multiforme rGBM) through suppression of overactive DNA repair activity |
Robert Kridel
|
2018-2021 |
Dissecting biological hererogeneity in follicular lymphoma into clinically relevant molecular subtypes |
For more information on the 2019 New Investigator Awards, including application guidelines and deadlines, please visit the award site: